UNII FYS6T7F842

ADALIMUMAB

UNII Information

Unique Ingredient Identifier: FYS6T7F842
The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
Preferred Substance Name: ADALIMUMAB
The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
Registry Number: 331731-18-1
The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
NCI Thesaurus Concept Code: C65216
The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
UNII to RxNorm Crosswalk: 327361 (RXCUI)
The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
INN ID: 7860
Sequential number assigned by World Health Organization's International Nonproprietary Name (INN).
Ingredient Type: INGREDIENT SUBSTANCE
Substance Type: 49c070a0-3b9f-4617-86ad-d5551a84fbab
The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.

UNII Synonyms and Mappings

The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.

  • ABP-501 - Code
  • ABRILADA - Brand/Trade Name
  • ADALIMUMAB - Name identified as having official status
  • ADALIMUMAB (ABBVIE) - Common Name
  • ADALIMUMAB (GENETICAL RECOMBINATION) - Common Name
  • ADALIMUMAB (GENETICAL RECOMBINATION) [JAN] - Common Name
  • ADALIMUMAB (HUMIRA) - Common Name
  • ADALIMUMAB [EMA EPAR] - Common Name
  • ADALIMUMAB [HSDB] - Common Name
  • ADALIMUMAB [INN] - Common Name
  • ADALIMUMAB [JAN] - Common Name
  • ADALIMUMAB [MART.] - Common Name
  • ADALIMUMAB [MI] - Common Name
  • ADALIMUMAB [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB [USAN] - Common Name
  • ADALIMUMAB [VANDF] - Common Name
  • ADALIMUMAB [WHO-DD] - Common Name
  • ADALIMUMAB ADAZ [WHO-DD] - Common Name
  • ADALIMUMAB ADBM [WHO-DD] - Common Name
  • ADALIMUMAB AFZB [WHO-DD] - Common Name
  • ADALIMUMAB AQVH [WHO-DD] - Common Name
  • ADALIMUMAB ATTO [WHO-DD] - Common Name
  • ADALIMUMAB BETA - Name identified as having official status
  • ADALIMUMAB BETA [INN] - Common Name
  • ADALIMUMAB BIOSIMILAR (ALVOTECH) - Common Name
  • ADALIMUMAB BIOSIMILAR (AMGEN) - Common Name
  • ADALIMUMAB BIOSIMILAR (AVT02) - Common Name
  • ADALIMUMAB BIOSIMILAR (BOEHRINGER INGELHEIM) - Common Name
  • ADALIMUMAB BIOSIMILAR (CELLTRION) - Common Name
  • ADALIMUMAB BIOSIMILAR (COHERUS BIOSCIENCES) - Common Name
  • ADALIMUMAB BIOSIMILAR (CT-P17) - Common Name
  • ADALIMUMAB BIOSIMILAR (FKB-327) - Code
  • ADALIMUMAB BIOSIMILAR (FUJIFILM KYOWA KIRIN BIOLOGICS) - Common Name
  • ADALIMUMAB BIOSIMILAR (MSB11022) - Common Name
  • ADALIMUMAB BIOSIMILAR (MYLAN) - Common Name
  • ADALIMUMAB BIOSIMILAR (PF-06410293) - Common Name
  • ADALIMUMAB BIOSIMILAR (PFIZER) - Common Name
  • ADALIMUMAB BIOSIMILAR (SAMSUNG BIOEPIS) - Common Name
  • ADALIMUMAB BIOSIMILAR (SANDOZ) - Common Name
  • ADALIMUMAB BIOSIMILAR (YUSIMRY) - Common Name
  • ADALIMUMAB BIOSIMILAR (ZRC-3197) - Common Name
  • ADALIMUMAB BWWD [WHO-DD] - Common Name
  • ADALIMUMAB FKJP [WHO-DD] - Common Name
  • ADALIMUMAB, LICENSE HOLDER UNSPECIFIED - Common Name
  • ADALIMUMAB-AACF - Name identified as having official status
  • ADALIMUMAB-AATY - Name identified as having official status
  • ADALIMUMAB-ADAZ - Name identified as having official status
  • ADALIMUMAB-ADAZ [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB-ADBM - Name identified as having official status
  • ADALIMUMAB-ADBM [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB-AFZB - Name identified as having official status
  • ADALIMUMAB-AQVH - Name identified as having official status
  • ADALIMUMAB-ATTO - Name identified as having official status
  • ADALIMUMAB-ATTO [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB-BWWD - Name identified as having official status
  • ADALIMUMAB-FKJP - Name identified as having official status
  • ADALIMUMAB-RYVK - Name identified as having official status
  • AMJEVITA - Brand/Trade Name
  • AMSPARITY - Brand/Trade Name
  • AVT02 - Code
  • AVT-02 - Code
  • BCD-057 - Common Name
  • BI 695501 [WHO-DD] - Common Name
  • BI695501 - Code
  • BI-695501 - Code
  • CHS-1420 - Common Name
  • CTP17 - Code
  • CT-P17 - Code
  • CYLTEZO - Common Name
  • D2E7 - Code
  • D3E7 - Code
  • EXEMPTIA - Brand/Trade Name
  • FKB-327 - Code
  • GP2017 - Code
  • GP-2017 - Code
  • HADLIMA - Brand/Trade Name
  • HULIO - Brand/Trade Name
  • HUMIRA - Brand/Trade Name
  • HYRIMOZ - Brand/Trade Name
  • IDACIO - Brand/Trade Name
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER - Common Name
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER - Common Name
  • LBAL - Common Name
  • LU200134 - Code
  • LU-200134 - Code
  • M923 - Code
  • M-923 - Common Name
  • MSB11022 - Code
  • MSB-11022 - Code
  • ONS-3010 - Common Name
  • PF-06410293 - Code
  • SB5 - Code
  • SB-5 - Code
  • SIMLANDI - Brand/Trade Name
  • TRUDEXA - Brand/Trade Name
  • YUFLYMA - Brand/Trade Name
  • YUSIMRY - Brand/Trade Name
  • ZRC3197 - Code
  • ZRC-3197 - Code

UNII Resources

Common Chemistry
CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
Inxight Drugs
The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
DailyMed Regulated Products
The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
NCATS GSRS Full Record
The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
NCI Thesaurus
NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.

UNII Crossover to NDC Codes

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0025-0319Proprietary Name: Abrilada Pfizer Laboratories Div Pfizer Inc
0025-0325Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0025-0328Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0025-0333Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0025-0347Proprietary Name: Abrilada Pfizer Laboratories Div Pfizer Inc
0069-0319Proprietary Name: Abrilada Pfizer Laboratories Div Pfizer Inc
0069-0325Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0069-0328Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0069-0333Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0069-0347Proprietary Name: Abrilada Pfizer Laboratories Div Pfizer Inc
0074-0067Proprietary Name: Humira Abbvie Inc.
0074-0124Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0243Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0554Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0616Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0817Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-1539Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-2540Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-3797Proprietary Name: Humira Abbvie Inc.
0074-3799Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-4339Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-6347Proprietary Name: Humira Abbvie Inc.
0074-9374Proprietary Name: Humira Abbvie Inc.
0597-0370Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0375Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0400Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0405Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0545Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0555Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0585Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0595Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
49502-380Proprietary Name: Hulio Adalimumab-fkjpKitViatris Specialty LlcACTIVE
49502-381Proprietary Name: Hulio Adalimumab-fkjpKitViatris Specialty LlcACTIVE
49502-382Proprietary Name: Hulio Adalimumab-fkjpKitViatris Specialty LlcACTIVE
49502-416Proprietary Name: Adalimumab Adalimumab-fkjpKitViatris Specialty LlcACTIVE
49502-417Proprietary Name: Adalimumab Adalimumab-fkjpKitViatris Specialty LlcACTIVE
49502-418Proprietary Name: Adalimumab Adalimumab-fkjpKitViatris Specialty LlcACTIVE
50090-4487Proprietary Name: Humira AdalimumabKitA-s Medication SolutionsACTIVE
50090-6411Proprietary Name: Amjevita A-s Medication Solutions
50090-6428Proprietary Name: Amjevita A-s Medication Solutions
50090-6704Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6705Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6706Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6707Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
51407-834Proprietary Name: Adalimumab AdalimumabKitGolden State Medical Supply Inc.ACTIVE
51407-835Proprietary Name: Adalimumab AdalimumabKitGolden State Medical Supply Inc.ACTIVE
51759-402Proprietary Name: Simlandi Adalimumab-ryvkKitSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
55513-400Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-410Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-411Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
61314-327Proprietary Name: Adalimumab Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-454Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-473Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-476Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-509Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-517Proprietary Name: Hyrimoz Adalimumab-adazKitSandoz IncACTIVE
61314-531Proprietary Name: Hyrimoz Adalimumab-adazKitSandoz IncACTIVE
65219-554Proprietary Name: Idacio Adalimumab-aacfKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-556Proprietary Name: Idacio Adalimumab-aacfKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-558Proprietary Name: Idacio Adalimumab-aacfKitFresenius Kabi Usa, LlcACTIVE
65219-612Proprietary Name: Adalimumab-aacf AdalimumabKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
70114-210Proprietary Name: Yusimry Coherus Biosciences IncINACTIVATED
70114-220Proprietary Name: Yusimry Coherus Biosciences IncINACTIVATED
71288-815Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
71288-816Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
72511-400Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.ACTIVE
72606-022Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-030Proprietary Name: Yuflyma AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-040Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-041Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
78206-183Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-184Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-185Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-186Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-187Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
82009-144Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitQuallent Pharmaceuticals Health LlcACTIVE
82009-146Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitQuallent Pharmaceuticals Health LlcACTIVE
82009-148Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitQuallent Pharmaceuticals Health LlcACTIVE
82009-150Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitQuallent Pharmaceuticals Health LlcACTIVE
82009-156Proprietary Name: Adalimumab-ryvk Adalimumab-ryvkKitSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
83257-016Proprietary Name: Hulio Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-017Proprietary Name: Hulio Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-019Proprietary Name: Hulio Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-020Proprietary Name: Adalimumab Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-021Proprietary Name: Adalimumab Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-022Proprietary Name: Adalimumab Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83457-100Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-101Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-102Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-103Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-124Proprietary Name: Humira AdalimumabKitCordavis LimitedACTIVE
83457-243Proprietary Name: Humira AdalimumabKitCordavis LimitedACTIVE
83457-554Proprietary Name: Humira AdalimumabKitCordavis LimitedACTIVE
83457-616Proprietary Name: Humira AdalimumabKitCordavis LimitedACTIVE
83457-817Proprietary Name: Humira AdalimumabKitCordavis LimitedACTIVE
84612-399Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-479Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-481Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-482Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE